XING-SHA Trademark

Trademark Overview


On Tuesday, November 9, 2021, a trademark application was filed for XING-SHA with the United States Patent and Trademark Office. The USPTO has given the XING-SHA trademark a serial number of 79331622. The federal status of this trademark filing is REGISTERED as of Tuesday, July 25, 2023. This trademark is owned by Sinopharm Xingsha Pharmaceuticals(XiaMen)CO.,LTD.. The XING-SHA trademark is filed in the Pharmaceutical Products category with the following description:

Medicines in form of tablet form for intestinal disorders; capsules for pharmaceutical purpose, namely, diet capsules; biological preparations for medical purposes for the treatment of intestinal disorders; pharmaceutical preparations for treating diabetes; chemical-pharmaceutical preparations, namely, chemical preparations for treating diabetes; vitamin preparations; drugs for medical purposes, namely, medicines for the treatment of diabetes; cod liver oil; greases for medical purposes; capsules for medicines, namely, diet capsules; medical preparations for human and animal use for the treatment of intestinal disorders; chemical preparations for medical purposes, namely, chemical preparations for treating intestinal disorders; chemical reagents for medical or veterinary purposes; chemical preparations for pharmaceutical purposes for the treatment of intestinal disorders; medicines for human purposes for the treatment of intestinal disorders
xing-sha

General Information


Serial Number79331622
Word MarkXING-SHA
Filing DateTuesday, November 9, 2021
Status700 - REGISTERED
Status DateTuesday, July 25, 2023
Registration Number7117205
Registration DateTuesday, July 25, 2023
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, May 9, 2023

Trademark Statements


Translation of Words in MarkThe wording "XING-SHA" has no meaning in a foreign language.
Goods and ServicesMedicines in form of tablet form for intestinal disorders; capsules for pharmaceutical purpose, namely, diet capsules; biological preparations for medical purposes for the treatment of intestinal disorders; pharmaceutical preparations for treating diabetes; chemical-pharmaceutical preparations, namely, chemical preparations for treating diabetes; vitamin preparations; drugs for medical purposes, namely, medicines for the treatment of diabetes; cod liver oil; greases for medical purposes; capsules for medicines, namely, diet capsules; medical preparations for human and animal use for the treatment of intestinal disorders; chemical preparations for medical purposes, namely, chemical preparations for treating intestinal disorders; chemical reagents for medical or veterinary purposes; chemical preparations for pharmaceutical purposes for the treatment of intestinal disorders; medicines for human purposes for the treatment of intestinal disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 31, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSinopharm Xingsha Pharmaceuticals(XiaMen)CO.,LTD.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCN

Party NameSinopharm Xingsha Pharmaceuticals(XiaMen)CO.,LTD.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN

Party NameSinopharm Xingsha Pharmaceuticals(XiaMen)CO.,LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Thursday, January 27, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, January 31, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 4, 2022APPLICATION FILING RECEIPT MAILED
Friday, August 19, 2022ASSIGNED TO EXAMINER
Monday, August 22, 2022NON-FINAL ACTION WRITTEN
Tuesday, August 23, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, October 14, 2022REFUSAL PROCESSED BY MPU
Friday, October 14, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, November 8, 2022REFUSAL PROCESSED BY IB
Wednesday, March 22, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 22, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 23, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 6, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, April 6, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, April 6, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 7, 2023EXAMINERS AMENDMENT MAILED
Friday, April 14, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 14, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 14, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, April 14, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 19, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 19, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 19, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, May 9, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 9, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, May 10, 2023NOTIFICATION PROCESSED BY IB
Wednesday, June 28, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, June 28, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, July 21, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, July 25, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, July 25, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, October 25, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, October 25, 2023GENERIC MADRID TRANSACTION CREATED
Thursday, October 26, 2023GENERIC MADRID TRANSACTION SENT TO IB
Monday, December 18, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, June 18, 2026NEW REPRESENTATIVE AT IB RECEIVED